A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [CLOSE]

Healthcare Providers: Ordering Monoclonal Antibody (mAb) Products

 

This page has been automatically translated from English. MSDH has not reviewed this translation and is not responsible for any inaccuracies.

If you are a healthcare provider and wish to order monoclonal antibody products, please see the guidance below.

Monoclonal antibody (mAb) products are available in the United States under an Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA) for early treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in patients who are at high risk for progression to severe COVID-19 and/or hospitalization or death. REGEN-COV and bamlanivimab/etesevimab are also authorized for post-exposure prophylaxis.*

* Note: Post-exposure prophylaxis with REGEN-COV and bamlanivimab/etesevimab are not substitutes for vaccination against COVID-19, and REGEN-COV and bamlanivimab/etesevimab are not authorized for pre-exposure prophylaxis.

Required Reporting

In order to continue to receive product, you must report weekly utilization to HHS and MSDH.

EUA Fact Sheets

Please see full EUAs from the FDA:

Ordering REGEN-COV (Regeneron)

  • Purchased by the U.S. Department of Health and Human Services
  • If you are an existing monoclonal antibody provider and would like to request an order, you will need to fill out the quantity requested on the Monoclonal Antibody REDCap Survey sent from MSDH to your facility each Tuesday. If you have not received the link to this survey, please e-mail C19Therapeutics@msdh.ms.gov.

Ordering Sotrovimab (GlaxoSmithKline)

  • Purchased by the U.S. Department of Health and Human Services
  • If you are an existing monoclonal antibody provider and would like to request an order, you will need to fill out the quantity requested on the Monoclonal Antibody REDCap Survey sent from MSDH to your facility each Tuesday. If you have not received the link to this survey, please e-mail C19Therapeutics@msdh.ms.gov.

Ordering Bamlanivimab/etesevimab (Eli Lilly)

  • Purchased by the U.S. Department of Health and Human Services
  • If you are an existing monoclonal antibody provider and would like to request an order, you will need to fill out the quantity requested on the Monoclonal Antibody REDCap Survey sent from MSDH to your facility each Tuesday. If you have not received the link to this survey, please e-mail C19Therapeutics@msdh.ms.gov.

If you have questions, please send e-mail to C19Therapeutics@msdh.ms.gov

Last reviewed on Jan 12, 2022
Sign up for COVID-19 e-mail updates with our free newsletter: 
Mississippi State Department of Health 570 East Woodrow Wilson Dr Jackson, MS 39216 866-HLTHY4U Contact and information

Facebook Twitter Instagram RSS

Accredited by the national Public Health Accreditation Board